TY - JOUR T1 - Suprascapular nerve block reduced chronic shoulder pain and disability in degenerative disease or rheumatoid arthritis JF - Evidence Based Medicine JO - Evid Based Med SP - 50 LP - 50 DO - 10.1136/ebm.9.2.50 VL - 9 IS - 2 A2 - , Y1 - 2004/03/01 UR - http://ebm.bmj.com/content/9/2/50.abstract N2 - Shanahan EM, Ahern M, Smith M, et al. Suprascapular nerve block (using bupivacaine and methylprednisolone acetate) in chronic shoulder pain. Ann Rheum Dis 2003;62:400–6.OpenUrlAbstract/FREE Full Text 
 
 Q In patients with chronic shoulder pain from degenerative disease or rheumatoid arthritis, is suprascapular nerve block (SNB) effective for reducing the resulting pain and disability? Clinical impact ratings GP/FP/Primary care ★★★★★☆☆ Rheumatology ★★★★★★☆ Design: randomised placebo controlled trial. Allocation: concealed.* Blinding: patients and outcome assessors.* Follow up period: 12 weeks. Setting: St Vincent’s University Hospital in Dublin, Ireland and the Repatriation Hospital in Adelaide, South Australia. Patients: 83 unselected patients (108 shoulders) (mean age 73 y, 52% men) with chronic shoulder pain of ⩾3 months’ duration resulting from degenerative disease (43 patients, 56 shoulders) or rheumatoid arthritis (40 patients, 52 shoulders). Exclusion criteria included a known allergy … ER -